Evidence map›Paper›PMID 40801878›Full record

ArticleThe Journal of cell biology2025

Origin of chromosome 12 trisomy surge in human induced pluripotent stem cells.

Maria Narozna, Megan C Latham, Gary J Gorbsky

Abstract read
In one paragraph

Article in The Journal of cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Maria NaroznaProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation , Oklahoma City, OK, USA.ORCID 0000-0001-6247-2079
Megan C LathamProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation , Oklahoma City, OK, USA.ORCID 0000-0001-7467-4719
Gary J GorbskyProgram in Cell Cycle and Cancer Biology, Oklahoma Medical Research Foundation , Oklahoma City, OK, USA.ORCID 0000-0003-3076-4725

Funding

Understanding Cell DivisionR35GM126980 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GARY J. GORBSKY · 2018 to 2026
$3.7M
McCasland FoundationNIGMS NIH HHS R35 GM126980NIGMS NIH HHS R35GM126980Oklahoma Center for Adult Stem Cell Research
6 · The paper itself

Abstract

Trisomy 12 is the most common whole-chromosome abnormality in human pluripotent stem cells. Conventionally, this acquired aneuploidy is ascribed to a rare single-cell event followed by selective growth advantage. Instead, we show that trisomy 12 emerges simultaneously in a very high percentage of cells in critical transition passages. Mis-segregation and incorporation of chromosome 12 into micronuclei occur through bridging of the short p arms of chromosome 12. Subsequently, single, unreplicated chromosome 12 chromatids are observed in mitotic cells. Erosion of the subtelomeric regions of the 12p arms is found during the passages when chromosome 12 bridges become frequent and trisomy 12 increases. Trisomy 12 cells persist due to a slight growth advantage. Among the shortest telomeres in humans are those on the 12p arms, making them particularly vulnerable to damage and bridging during mitosis. These findings reveal a novel mechanism of whole-chromosome instability in human stem cells, with broad implications for understanding the genesis of aneuploidy across diverse biological systems.

Indexed as

Chromosomes, Human, Pair 12Induced Pluripotent Stem CellsTrisomyAneuploidyChromosomal InstabilityHumansMitosisTelomere

Identifiers

PMID40801878
PMCPMC12970407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.